These are the biotech stocks to buy that can deliver 100% to 300% returns within the next six months. Acasti Pharma (ACST): GTX-104 is in the third stage of clinical trials and is a potential catalyst...
Source LinkThese are the biotech stocks to buy that can deliver 100% to 300% returns within the next six months. Acasti Pharma (ACST): GTX-104 is in the third stage of clinical trials and is a potential catalyst...
Source Link
Comments